VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Canadian Small/Micro Cap Top picks for 2021

<< Previous

Bullboard Posts

Next >>

Comment by GrahamBon Jan 09, 2021 2:52pm

174 Views

Post# 32261669

RE:RE:RE:RE:RE:RE:RE:Canadian Small/Micro Cap Top picks for 2021

A question is how will they execute sales if they are now reducing the
cash burn to avoid liquidity concerns?

Who is in the sales team?

They may cut back on expenses, but if they don't grow the sales team how will they move the units?

I saw that Dave McPhedran was Director of sales, but in July the title on the web changed to consultant.

So has the position/commitment changed?
Who is heading the initiation and follow up of sales contacts?

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing